165 related articles for article (PubMed ID: 6627288)
21. New indices in the evaluation of clonidine transdermal therapy of hypertension.
de Leonardis V; de Scalzi M; Becucci A; Lusini C; Cinelli P
Int J Clin Pharmacol Res; 1989; 9(5):341-5. PubMed ID: 2625373
[TBL] [Abstract][Full Text] [Related]
22. Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hypertensive males.
Schmidt GR; Schuna AA; Goodfriend TL
J Clin Pharmacol; 1989 Feb; 29(2):133-9. PubMed ID: 2715369
[TBL] [Abstract][Full Text] [Related]
23. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.
Ishii R; Furuta M; Hashimoto M; Tagawa T; Naruse T; Hata T
Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708
[TBL] [Abstract][Full Text] [Related]
24. Treatment of hypertension by a new transdermal form of clonidine.
Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
[TBL] [Abstract][Full Text] [Related]
25. Postoperative analgesia using a low-dose, oral-transdermal clonidine combination: lack of clinical efficacy.
Owen MD; Fibuch EE; McQuillan R; Millington WR
J Clin Anesth; 1997 Feb; 9(1):8-14. PubMed ID: 9051539
[TBL] [Abstract][Full Text] [Related]
26. [Transdermal clonidine: a new therapeutic approach in essential hypertension?].
Groth H; Greminger P; Vetter H; Knüsel J; Baumgart P; Siegenthaler W; Vetter W
Schweiz Rundsch Med Prax; 1985 Mar; 74(11):265-9. PubMed ID: 3158058
[No Abstract] [Full Text] [Related]
27. [Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children].
Kang H; Zhang YF; Jiao FY; Guo XY; Gao XM
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):537-9. PubMed ID: 19650984
[TBL] [Abstract][Full Text] [Related]
28. Rebound hypertension after discontinuation of transdermal clonidine.
Schmidt GR; Schuna AA
Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
[No Abstract] [Full Text] [Related]
29. Transdermal clonidine in the treatment of adolescent hypertension.
Falkner B; Thanki B; Lowenthal DT
J Hypertens Suppl; 1985 Dec; 3(4):S61-3. PubMed ID: 3868713
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
Weir MR; Lavin PT; Byrnes CA
Clin Ther; 1993; 15(3):527-38. PubMed ID: 8364944
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
[TBL] [Abstract][Full Text] [Related]
32. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial.
Zeller KR; Von Kuhnert L; Matthews C
Arch Intern Med; 1989 Oct; 149(10):2186-9. PubMed ID: 2679473
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for severe bradycardia during oral clonidine therapy for hypertension.
Byrd BF; Collins HW; Primm RK
Arch Intern Med; 1988 Mar; 148(3):729-33. PubMed ID: 3341873
[TBL] [Abstract][Full Text] [Related]
34. Transdermal administration of clonidine: a new approach to antihypertensive therapy.
Burris JF; Mroczek WJ
Pharmacotherapy; 1986; 6(1):30-4. PubMed ID: 3952004
[TBL] [Abstract][Full Text] [Related]
35. Clonidine and prazosin in the treatment of hypertensive outpatients--a preliminary study.
González-Gómez A; Díaz Novás J; Gamio Capestany F; Rodríguez de la Vega A; García-Barreto D
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):524-8. PubMed ID: 6642791
[TBL] [Abstract][Full Text] [Related]
36. Transdermal clonidine as an adjunct to enalapril: an evaluation of efficacy and patient compliance.
Weidler D; Wallin JD; Cook E; Dillard D; Lewin A
J Clin Pharmacol; 1992 May; 32(5):444-9. PubMed ID: 1587962
[TBL] [Abstract][Full Text] [Related]
37. Transdermal and oral clonidine.
Lilja M; Juustila H; Sarna S; Jounela AJ
Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
[TBL] [Abstract][Full Text] [Related]
38. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
39. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
40. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
